Loading... Please wait... Loading... Please wait...
ESTIMATED
05/15/2024
05/15/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.45 | -$0.45 | -$0.45 |
| Q2 2024 | 2 | -$0.48 | -$0.42 | -$0.45 |
| Q3 2024 | 0 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2024 | 0 | -$0.42 | -$0.42 | -$0.42 |
Biora Therapeutics, Inc. last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-0.61 earnings per share for the quarter, missing analysts' consensus estimates of $-0.45 by $0.16. The company had revenue of 542,000 for the quarter and had revenue of 4,000 for the year. Biora Therapeutics, Inc. has generated $-8 earnings per share over the last year ($-7.87 diluted earnings per share) and currently has a price-to-earnings ratio of -0.16. Biora Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q1 2024 | -$0.45 | -$0.14 | 0.31 | $542,000 | $542,000 | 04/01/2024 | Q4 2023 | -$0.62 | $500 | $872,000 | 11/13/2023 | Q3 2023 | -$0.93 | -$4.89 | -3.96 | $0 | 08/14/2023 | Q2 2023 | -$1.60 | -$1.47 | 0.13 | $2,000 | 05/15/2023 | Q1 2023 | -$1.75 | -$2.01 | -0.26 | $2,000 | 03/30/2023 | Q4 2022 | -$0.89 | -$1.61 | -0.72 | $110,000 | $14,000 | 11/14/2022 | Q3 2022 | -$1.50 | -$1.99 | -0.49 | $80,000 | 08/15/2022 | Q2 2022 | -$3.25 | -$0.81 | 2.44 | $104,000 | 05/10/2022 | Q1 2022 | -$3.00 | $0.08 | 3.08 | $107,000 | 03/28/2022 | Q4 2021 | -$4.00 | -$13.98 | -9.98 | $250,000 | $435,000 | 11/10/2021 | Q3 2021 | -$11.17 | -$11.41 | -0.24 | $3.80 M | $182,000 | 08/12/2021 | Q2 2021 | -$20.17 | -$30.70 | -10.53 | $20.74 M | $463,000 | 05/13/2021 | Q1 2021 | -$20.30 | -$14.03 | 6.27 | $24.53 M | 03/18/2021 | Q4 2020 | -$20.55 | -$38.31 | -17.76 | $24.71 M | $14.28 M | 11/09/2020 | Q3 2020 | -$17.90 | -$25.23 | -7.33 | $34.74 M | $25.94 M | 08/14/2020 | Q2 2020 | -$151.90 | $26.18 M | $17.27 M | 03/31/2020 | Q1 2020 | -$9.49 | $16.83 M | 12/31/2019 | Q4 2019 | $0.00 | $20.48 M | 09/29/2019 | Q3 2019 | -$40.74 | $18.77 M | 06/29/2019 | Q2 2019 | -$11.70 | $57.23 M |
|---|
A. Biora Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for Biora Therapeutics, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Biora Therapeutics, Inc.'s latest earnings report can be read online.
A. Biora Therapeutics, Inc. (NASDAQ:BIOR) has a recorded annual revenue of $4,000.
A. Biora Therapeutics, Inc. (NASDAQ:BIOR) has a recorded net income of $4,000. Biora Therapeutics, Inc. has generated $-7.87 earnings per share over the last four quarters.
A. Biora Therapeutics, Inc. (NASDAQ:BIOR) has a price-to-earnings ratio of -0.16 and price/earnings-to-growth ratio is 0.01.
